These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9001435)

  • 1. Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA).
    Kroft SH; Tallman MS; Shaw JM; Thangavelu M; Peterson LC
    Leukemia; 1997 Jan; 11(1):170. PubMed ID: 9001435
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia.
    Robak T; Sysa-Jedrzejowska A; Robak E; Dabkowski J; Blasinska-Morawiec M
    J Med; 1997; 28(3-4):199-209. PubMed ID: 9355024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
    Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
    Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
    [No Abstract]   [Full Text] [Related]  

  • 4. Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
    Murphy PT; Mitra S; O'Donghaile D
    Am J Hematol; 2006 Jun; 81(6):473. PubMed ID: 16680754
    [No Abstract]   [Full Text] [Related]  

  • 5. Cladribine in the treatment of chronic lymphocytic leukemia.
    Robak T
    Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.
    Robak T; Błasińska-Morawiec M; Błoński JZ; Dmoszyńska A
    Leuk Lymphoma; 1999 Jun; 34(1-2):151-7. PubMed ID: 10350343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
    Krykowski E; Warzocha K; Robak T
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.
    Robak T; Urbańska-Ryś H; Strzelecka B; Krykowski E; Bartkowiak J; Bĺoński JZ; Kordek R; Warzocha K
    Eur J Haematol; 2001; 67(5-6):322-7. PubMed ID: 11872081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab and myelodysplasia: a story of love and hate (possible alemtuzumab-induced myelodysplastic changes).
    Braester A; Akria L; Suriu C; Sonkin V
    Acta Haematol; 2013; 129(3):185-6. PubMed ID: 23257842
    [No Abstract]   [Full Text] [Related]  

  • 11. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A; Lemon RH; Piro LD
    N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
    Robak T; Błasinka-Morawiec M; Krykowski E; Kasznicki M; Płuzanska A; Potemski P; Hellmann A; Zaucha JM; Lewandowski K; Dmoszynska A; Hansz J; Komarnicki M; Konopka L; Durzynski T; Ceglarek B; Sikorska A; Kotlarek-Haus S; Mazur G; Urasinski I; Zdziarska B; Maj S; Kopec I; Skotnicki AB; Dwilewicz-Trojaczek J; Grieb P
    Leuk Lymphoma; 1996 Aug; 22(5-6):509-14. PubMed ID: 8882965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.
    Saven A; Lemon RH; Kosty M; Beutler E; Piro LD
    J Clin Oncol; 1995 Mar; 13(3):570-4. PubMed ID: 7884417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia.
    Rossini MS; de Souza EM; Cintra ML; Pagnano KB; Chiari AC; Lorand-Metze I
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):538-42. PubMed ID: 15324388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of myelodysplastic syndrome in a patient with chronic myelogenous leukemia treated with imatinib.
    Mallik N; Chopra A; Jha A; Gogia A; Kumar R
    Leuk Lymphoma; 2015 Apr; 56(4):1143-4. PubMed ID: 25093381
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.
    Park TS; Cheong JW; Song J; Choi JR
    Leuk Res; 2009 Jul; 33(7):1001-4. PubMed ID: 19155067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
    Schirmer M; Michlmayr G; Geisen F; Konwalinka G
    Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
    [No Abstract]   [Full Text] [Related]  

  • 18. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.
    Robak T; Blonski JZ; Gora-Tybor J; Kasznicki M; Konopka L; Ceglarek B; Komarnicki M; Lewandowski K; Hellmann A; Lewandowski K; Moskwa A; Dmoszyńska A; Sokołowska B; Dwilewicz-Trojaczek A; Tomaszewska A; Sułek K; Całbecka M
    Eur J Cancer; 2004 Feb; 40(3):383-9. PubMed ID: 14746857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosomy 7 myelodysplasia in childhood. Two case reports.
    Yeşilipek MA; Lüleci G; Velipaşaoğlu S; Berker S; Yeğin O
    Acta Haematol; 1994; 92(1):36-8. PubMed ID: 7985480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of myeloma in a chronic lymphocytic leukemia patients after response to differentiation therapy with interleukin-4.
    Makower D; Venkatraj U; Dutcher JP; Wiernik PH
    Leuk Lymphoma; 1996 Nov; 23(5-6):617-9. PubMed ID: 9031095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.